CCR5 and HIV-1 infection: CCR5 Δ32 heterozygous genotype showed delayed but not completely prevented HIV-1 infection underlines the need for biallelic CCR5 editing (47).The mathematical modeling predicted that the autologous HSPC graft with an editing efficiency of 76% or greater is required to control the viral rebound (48).